The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-Disciplinary Collaboration
creating positive experiences and outcomes.

Mission

Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.

CORE PILLARS

HAVN Labs

Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.


350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.

0

Formulas standardized across clinical studies of psychedelic compounds.

Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE …

Read More →
Press Releases

Havn Life Sciences and Nesters Market, a leading Canadian retailer of Natural Health and Wellness Products, announce an authorized products listing

Nesters Market retail chain, will list and promote the full range of Havn Life’s natural health supplements across its stores in British Columbia in Q1 …

Read More →
Press Releases

Havn Life Sciences Files Preliminary Prospectus in Connection with Bought Deal Equity Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES December 18, 2020 – Vancouver, BC – Havn Life Sciences Inc. …

Read More →
Scroll to Top